BIONTECH SE

BNTX
Delayed Quote. Delayed  - 09/22 04:00:00 pm
67.05USD +1.41%
Prev.66.1200
Open65.3800
High67.7573
Low63.6100
Volume1 572 284
Latest news
21h ago
4d ago
4d ago
4d ago
Chart BIONTECH SE
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance73,010485,3
Spread/Res.-8,2%-36%-21%
Spread/Supp.16%74%76%
Support57,838,638,1
Financials
Sales 2020 475 M 555 M 555 M
Net income 2020 -99,8 M -117 M -117 M
Net cash 2020 1 191 M 1 391 M 1 391 M
P/E ratio 2020 -95,6x
Yield 2020 -
Capitalization 13 640 M 15 970 M 15 940 M
EV / Sales 2020 26,2x
EV / Sales 2021 4,27x
Nbr of Employees 1 400
Free-Float 92,4%
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-10 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 68,12 €
Last Close Price 57,27 €
Spread / Highest target 46,7%
Spread / Average Target 18,9%
Spread / Lowest Target -17,3%